These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 11442750

  • 1. Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation.
    Bachmann F, Buechner SA, Wernli M, Strebel S, Erb P.
    J Invest Dermatol; 2001 Jul; 117(1):59-66. PubMed ID: 11442750
    [Abstract] [Full Text] [Related]

  • 2. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH, Ajaz M, Lokshin A, Lee YJ.
    Clin Cancer Res; 2003 Aug 01; 9(8):3134-41. PubMed ID: 12912965
    [Abstract] [Full Text] [Related]

  • 3. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.
    Cell Death Differ; 2004 Jul 01; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [Abstract] [Full Text] [Related]

  • 4. Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis.
    Zang DY, Goodwin RG, Loken MR, Bryant E, Deeg HJ.
    Blood; 2001 Nov 15; 98(10):3058-65. PubMed ID: 11698291
    [Abstract] [Full Text] [Related]

  • 5. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
    Mirandola P, Ponti C, Gobbi G, Sponzilli I, Vaccarezza M, Cocco L, Zauli G, Secchiero P, Manzoli FA, Vitale M.
    Blood; 2004 Oct 15; 104(8):2418-24. PubMed ID: 15205263
    [Abstract] [Full Text] [Related]

  • 6. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
    Ahmad M, Shi Y.
    Oncogene; 2000 Jul 13; 19(30):3363-71. PubMed ID: 10918593
    [Abstract] [Full Text] [Related]

  • 7. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
    Kamohara H, Matsuyama W, Shimozato O, Abe K, Galligan C, Hashimoto S, Matsushima K, Yoshimura T.
    Immunology; 2004 Feb 13; 111(2):186-94. PubMed ID: 15027904
    [Abstract] [Full Text] [Related]

  • 8. Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells.
    Clodi K, Wimmer D, Li Y, Goodwin R, Jaeger U, Mann G, Gadner H, Younes A.
    Br J Haematol; 2000 Nov 13; 111(2):580-6. PubMed ID: 11122106
    [Abstract] [Full Text] [Related]

  • 9. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
    Leverkus M, Neumann M, Mengling T, Rauch CT, Bröcker EB, Krammer PH, Walczak H.
    Cancer Res; 2000 Feb 01; 60(3):553-9. PubMed ID: 10676636
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
    Choi YJ, Baranowska-Daca E, Nguyen V, Koji T, Ballantyne CM, Sheikh-Hamad D, Suki WN, Truong LD.
    Kidney Int; 2000 Oct 01; 58(4):1481-91. PubMed ID: 11012883
    [Abstract] [Full Text] [Related]

  • 11. Resistance of human melanoma cells against the death ligand TRAIL is reversed by ultraviolet-B radiation via downregulation of FLIP.
    Zeise E, Weichenthal M, Schwarz T, Kulms D.
    J Invest Dermatol; 2004 Oct 01; 123(4):746-54. PubMed ID: 15373780
    [Abstract] [Full Text] [Related]

  • 12. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.
    Olsson A, Diaz T, Aguilar-Santelises M, Osterborg A, Celsing F, Jondal M, Osorio LM.
    Leukemia; 2001 Dec 01; 15(12):1868-77. PubMed ID: 11753607
    [Abstract] [Full Text] [Related]

  • 13. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
    Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace AJ, el-Deiry WS.
    Cancer Res; 1998 Apr 15; 58(8):1593-8. PubMed ID: 9563466
    [Abstract] [Full Text] [Related]

  • 14. The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
    Sheikh MS, Huang Y, Fernandez-Salas EA, El-Deiry WS, Friess H, Amundson S, Yin J, Meltzer SJ, Holbrook NJ, Fornace AJ.
    Oncogene; 1999 Jul 15; 18(28):4153-9. PubMed ID: 10435597
    [Abstract] [Full Text] [Related]

  • 15. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.
    Wendling U, Walczak H, Dörr J, Jaboci C, Weller M, Krammer PH, Zipp F.
    Cell Death Differ; 2000 Jul 15; 7(7):637-44. PubMed ID: 10889508
    [Abstract] [Full Text] [Related]

  • 16. Potential mechanisms of resistance to TRAIL/Apo2L-induced apoptosis in human promyelocytic leukemia HL-60 cells during granulocytic differentiation.
    Shiiki K, Yoshikawa H, Kinoshita H, Takeda M, Ueno A, Nakajima Y, Tasaka K.
    Cell Death Differ; 2000 Oct 15; 7(10):939-46. PubMed ID: 11279540
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.
    Hueber A, Aduckathil S, Kociok N, Welsandt G, Dinslage S, Kirchhof B, Esser PJ.
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul 15; 240(7):551-6. PubMed ID: 12136286
    [Abstract] [Full Text] [Related]

  • 18. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma.
    Zhang XD, Franco A, Myers K, Gray C, Nguyen T, Hersey P.
    Cancer Res; 1999 Jun 01; 59(11):2747-53. PubMed ID: 10364001
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.
    Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419
    [Abstract] [Full Text] [Related]

  • 20. Tissue distribution of the death ligand TRAIL and its receptors.
    Spierings DC, de Vries EG, Vellenga E, van den Heuvel FA, Koornstra JJ, Wesseling J, Hollema H, de Jong S.
    J Histochem Cytochem; 2004 Jun 15; 52(6):821-31. PubMed ID: 15150291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.